Analyst Price Targets — AMN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 20, 2026 1:45 pm | — | UBS | $19.50 | $18.05 | TheFly | AMN Healthcare price target raised to $19.50 from $19 at UBS |
| February 20, 2026 12:16 pm | Mark Marcon | Robert W. Baird | $23.00 | $17.28 | TheFly | AMN Healthcare price target raised to $23 from $21 at Baird |
| January 15, 2026 12:14 pm | — | J.P. Morgan | $25.00 | $19.55 | TheFly | AMN Healthcare price target raised to $25 from $22 at BMO Capital |
| October 13, 2025 11:46 am | — | Truist Financial | $24.00 | $18.70 | TheFly | AMN Healthcare price target raised to $24 from $20 at Truist |
| August 11, 2025 1:32 pm | Jeffrey Silber | BMO Capital | $22.00 | $16.71 | TheFly | AMN Healthcare price target lowered to $22 from $27 at BMO Capital |
| April 15, 2025 12:30 pm | Tobey Sommer | Truist Financial | $25.00 | $19.11 | TheFly | AMN Healthcare price target lowered to $25 from $40 at Truist |
| November 11, 2024 1:09 pm | Jeffrey Silber | BMO Capital | $46.00 | $39.75 | StreetInsider | AMN Healthcare (AMN) PT Lowered to $46 at BMO Capital |
| October 22, 2024 6:36 am | Constantine Davides | JMP Securities | $57.00 | $39.59 | TheFly | AMN Healthcare price target lowered to $57 from $66 at JMP Securities |
| October 21, 2024 8:00 am | Tobey Sommer | Truist Financial | $50.00 | $41.01 | TheFly | AMN Healthcare price target lowered to $50 from $70 at Truist |
| May 13, 2024 8:18 am | Jeffrey Silber | BMO Capital | $71.00 | $58.44 | StreetInsider | AMN Healthcare (AMN) PT Lowered to $71 at BMO Capital |
Latest News for AMN
Broker upgrades and rising earnings estimates highlight stocks like ARW, GOLD, CCRN, AMN and PENN amid geopolitical tensions and tech-sector volatility.
Survey of 700+ executives shows AI leadership roles surging as succession planning and clinician engagement lag Survey of 700+ executives shows AI leadership roles surging as succession planning and clinician engagement lag
AMN's Q4 2025 benefited from labor disruption revenue. However, ex-disruption revenue still exceeded the guidance midpoint. In my view, this supports my bull case on their core demand, which remained healthy. However, until we see a sustained trend, it's an inherently speculative view. AMN helps its healthcare clients with staffing, physician/leadership placement, and technology/workforce solutions.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Counterpoint Mutual Funds LLC grew its stake in AMN Healthcare Services Inc (NYSE: AMN) by 20.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 151,040 shares of the company's stock after acquiring an additional 25,958 shares during the period. AMN Healthcare Services comprises 0.2%
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AMN.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.